BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 19471238)

  • 1. Molecular basis of adrenocortical carcinomas.
    Soon PS; Sidhu SB
    Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
    Bussey KJ; Demeure MJ
    Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocortical carcinoma.
    Soon PS; Sidhu SB
    Cancer Treat Res; 2010; 153():187-210. PubMed ID: 19957226
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenocortical carcinoma.
    Rodgers SE; Evans DB; Lee JE; Perrier ND
    Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know.
    Ganeshan D; Bhosale P; Kundra V
    AJR Am J Roentgenol; 2012 Dec; 199(6):1283-93. PubMed ID: 23169720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma.
    Giordano TJ
    Am J Surg Pathol; 2011 Apr; 35(4):471-3. PubMed ID: 21383612
    [No Abstract]   [Full Text] [Related]  

  • 9. Current and emerging therapies for adrenocortical carcinoma--review.
    Przytulska J; Rogala N; Bednarek-Tupikowska G
    Adv Clin Exp Med; 2015; 24(2):185-93. PubMed ID: 25931348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in adrenocortical carcinoma in adults.
    Bourdeau I; MacKenzie-Feder J; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):192-7. PubMed ID: 23549307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in adrenocortical tumors.
    Reincke M
    Horm Metab Res; 1998; 30(6-7):447-55. PubMed ID: 9694578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical cancer treatment.
    Patalano A; Brancato V; Mantero F
    Horm Res; 2009 Jan; 71 Suppl 1():99-104. PubMed ID: 19153517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the treatment of adrenocortical carcinomas].
    Ducry J; Berthold D; Pralong F
    Rev Med Suisse; 2012 Nov; 8(362):2181-4, 2186. PubMed ID: 23240320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical cancer: pathophysiology and clinical management.
    Libè R; Fratticci A; Bertherat J
    Endocr Relat Cancer; 2007 Mar; 14(1):13-28. PubMed ID: 17395972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors.
    Soon PS; Libe R; Benn DE; Gill A; Shaw J; Sywak MS; Groussin L; Bertagna X; Gicquel C; Bertherat J; McDonald KL; Sidhu SB; Robinson BG
    Ann Surg; 2008 Jan; 247(1):157-64. PubMed ID: 18156936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.
    Strosberg JR
    Semin Oncol; 2013 Feb; 40(1):120-33. PubMed ID: 23391119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a pathway-centered approach for the treatment of adrenocortical carcinoma.
    Bussey KJ; Demeure MJ
    Curr Opin Oncol; 2011 Jan; 23(1):34-44. PubMed ID: 21045685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PERSONALIZED CARE OF PATIENTS WITH ADRENOCORTICAL CARCINOMA: A COMPREHENSIVE APPROACH.
    Miller BS; Else T;
    Endocr Pract; 2017 Jun; 23(6):705-715. PubMed ID: 28614035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical carcinoma.
    Baudin E;
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
    Elfiky AA; Krishnan Nair HK
    Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.